Now Credit Card Companies Want Your DNA
By Martha C. White,
Time: Moneyland
| 10. 27. 2011
A
Wall Street Journal article earlier this week reported that Visa and MasterCard are exploring new ways to take data about your buying habits in the brick-and-mortar world and let online marketers use that information to target you with ads when you browse the web. But buried a little ways down in the article are some details that are considerably more alarming. Visa, the article says, wants access to everything from your insurance claim history to your Facebook friends list to your DNA. Yes, you read that right:
According to a Visa patent application published in April, the company sees potential to use a wide array of personal details to create profiles that could be used for ad targeting well beyond shopping details. It describes the possibility of also using “information from social network websites, information from credit bureaus, information from search engines, information about insurance claims, information from DNA databanks,” and other sources.
This is a huge can of worms, warns Lillie Coney, associate director of the Electronic Privacy Information Center. “This is going to be problematic,” she says...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...